OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Gastroenterology & Hepatology is 70. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Genetic factors in alcohol-related cirrhosis	1014
Microbial cues stimulate linear growth in undernourished mice	789
Crosstalk between enteric neurons and colorectal cancer stem cells influences self-renewal	578
Regulating protease homeostasis in irritable bowel syndrome	465
Detecting gut osmolality changes to quench thirst	460
IVF in women with chronic liver disease or post-liver transplantation	405
Sugar intake during adolescence and risk of colorectal polyps	346
No beneficial effect of G-CSF in treating ACLF	289
Jumping the chasm from postdoc to PI	278
Showing a sensitive side	268
Understanding remodelling of bile ducts to promote polycystic liver disease	255
Inter-disciplinary collaboration for innovation in gastroenterology	250
The challenges facing female transplant hepatologists as young faculty	244
A Roadmap for the Human Gut Cell Atlas	234
Hippo signalling in the liver: role in development, regeneration and disease	232
Mirikizumab for inducing and maintaining clinical remission in ulcerative colitis	228
Hybrid EASL Congress 2023	216
Microbiota-based biomarkers and therapeutics for cancer management	208
Neuropod cells — sensing a sweet spot in the gut	208
Rectally shed SARS-CoV-2 lacks infectivity: time to rethink faecal–oral transmission?	207
Pouchitis: pathophysiology and management	205
Hybrid APASL meeting 2024	199
Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus	197
Achieving health equity in liver disease pharmacotherapy	196
Striving to optimize colorectal cancer prevention	193

ZBTB46+ ILC3s promote intestinal health	191
Effect of bariatric surgery on risk of oesophagogastric cancer	191
A role for the gut microbiota in immune checkpoint inhibitor-induced colitis	179
Machine perfusion of the liver: applications in transplantation and beyond	173
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases	169
Justice, equity, diversity and inclusion in gastroenterology and hepatology	163
Mapping neuroimmune interactions in the gut	160
Anti-SARS-CoV-2 vaccine in liver transplantation	151
Promoting allyship to support and uplift the LGBTQIA+ community	142
Rhythmicity of infant microbiota and dietary effects	135
Telemedicine for hepatitis C virus treatment in opioid treatment programmes	133
Insight into virome development	124
Long-term normothermic liver perfusion	123
Intestinal organ chips for disease modelling and personalized medicine	121
Celebrating 20 years of Nature Reviews Gastroenterology & Hepatology	119
Zolbetuximab treatment in metastatic gastric cancer	113
Is less more? Challenging dogma for individualized fluid resuscitation	113
Hepatitis D virus: more attention needed	111
Human hepatocyte organoids model early NAFLD	109
Comparing elimination diet therapies for eosinophilic oesophagitis	103
Long-term dynamic ex vivo organ preservation	102
Sphingolipids in hepatic metabolism	100
Examining the prevalence of NAFLD and NASH in a US cohort	99
Molecular landscape of NASH-HCC	95
2023 FDA approvals in gastroenterology and hepatology	92
A gut–liver axis in intestinal stem cell fitness	92
Contrasting aspects of human excreta	91
Disability inclusion in research and health care	90
Western lifestyle, metaflammation and the cell of origin of colon cancer	90
Metabolism of 5-ASA by the gut microbiome	89
Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications	88
High-density lipoprotein lipidome: a neglected source of hepatic lipids	87
Alcohol-free and low-strength drinks: friend or foe?	86
Equitable partnerships and the path to inclusive, innovative and impactful human microbiome research	85
Dietary and metabolic effects on intestinal stem cells in health and disease	85
Immunosuppressive IBD drugs and COVID-19 vaccine immunogenicity	82
Exploring liver cancer biology through functional genetic screens	81
Macrophages in intestinal homeostasis and inflammatory bowel disease	80
What are the clinical settings and outcomes of lean NAFLD?	79
Enteric glial biology, intercellular signalling and roles in gastrointestinal disease	78
A serious side to social media	75
Fetal liver development and implications for liver disease pathogenesis	74
Nomenclature of HBV core protein-targeting antivirals	73
Re-examining chemically defined liquid diets through the lens of the microbiome	73
Current developments in gastric cancer: from molecular profiling to treatment strategy	72
Artificial intelligence and automation in endoscopy and surgery	70